Abstract:Introduction: Despite advancements in cancer therapy, health disparities persist among underrepresented populations, including racial and ethnic minorities, people of low socioeconomic status, and people in geographically isolated areas. Representation in Early-Phase Clinical Trials (EPCT) is important, as limited representation exacerbates said inequities. Underrepresentation in clinical trials (CTs) impacts the true understanding of cancer biology and its role in treatment development. We aim to identify barriers and promoting factors influencing patients' decisions to enroll in EPCTs and identify interventions to increase minority enrollment in clinical trials using a survey-based questionnaire. Methods: Following the extensive literature review, a list of validated questions were collected to populate a questionnaire to evaluate common themes faced by patients in participation in EPCT. This survey was offered to patients with cancer seen at the University of Kansas Cancer Center. This study is IRB-approved (STUDY00150640). Descriptive analysis was performed with Chi-Square and Fisher's Exact Tests to determine significant associations between the qualitative variables to evaluate the most pressing barriers that were perceived in access to EPCT. Results: A total of 108 responses were collected. Over 58% of patients were over 65 years old. 62.4% were white, 17.8% African American, and 19.8% others (Asian or Native American). 40% of pts did not know about EPCTs before the survey. Only 26% of responders expressed participating in EPCTs in the past. Most people believe EPCTs are accessible to the public (75%) and would benefit from disease improvement (42%). Personal reasons for participating in EPCTs include obtaining a sense of hope (62%) and expressing no other treatment options available (49%). Encouragement to join EPCTs centered around wishing to help future cancer patients (67%) and trusting the center conducting the trial (52%). Pts emphasized the greatest benefit of participation in trials was the support of family and friends (69%). The top three perceived factors impacting EPCT accessibility from the pts perspective included understanding the value of the trial (76%), poor understanding of CTs process (40%), and lack of information of CTs (39%). Significant associations were observed with previous participation of EPCTs and increased age (p-value 0.031). An association was found with the responder's self-identified race and perceived accessibility of EPCTs for the public(p-value 0.007). Conclusion: Most responders believed that EPCTs are readily available to others though the most noted barriers included individual perspectives about attributed trial value and purpose. Many pts noted a belief that EPCT involvement would increase hope regarding therapy and a personal desire to help future cancer patients. This will provide a foundational landmark for creating initiatives and interventions that will enhance diversity and access of EPCTs to the community. This project is supported by the University of Kansas Cancer Center P30CA168524. Citation Format: Issa Jimenez Espinoza, Anusha Chidharla, Kamiyah Hicks, Dinesh Pal Mudaranthakam, Sam Pepper, Angelica Allen, Asuka Suzuki, Debra Sullivan, Jill Hamilton-Reeves, Anup Kasi, Rahul Parikh, Saqib Abbasi, Al-Ola Abdallah, Elizabeth Wulff- Burchfield, Anna Arthur, Lori Barbosa, Erin Carroll, Jennifer Heins, Hope Krebiill, Tara Lin, Gary Doolittle, Weijing Sun, Joaquina Baranda. Understanding Barriers to Equity in Early Phase Clinical Trials Participation for the – Underrepresented Populations (uBEEP-UP Project)- A single-center survey-based study [abstract]. In: Proceedings of the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2024 Sep 21-24; Los Angeles, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2024;33(9 Suppl) nr B122.

Modifications of the readiness assessment for pragmatic trials tool for appropriate use with Indigenous populations

Best Practice Recommendations for Integrating Health Equity into Pragmatic Clinical Trials for Dementia Care

Strengths, challenges, and strategies for implementing pragmatic multicenter randomized controlled trials (RCTs): example of the Personalized Citizen Assistance for Social Participation (APIC) trial

Randomised clinical trial research within Aboriginal and Torres Strait Islander primary health services: a qualitative study

Factors Affecting Post-trial Sustainment or De-implementation of Study Interventions: A Narrative Review

Considerations When Designing and Implementing Pragmatic Clinical Trials That Include Older Hispanics

Randomized controlled trial demonstrates novel tools to assess patient outcomes of Indigenous cultural safety training

Protocol for an adaptive platform trial of intended service user-derived interventions to equitably reduce non-attendance in eye screening programmes in Botswana, India, Kenya & Nepal

Abstract B160: Assessing patient experience in cancer clinical trial participants: Results from a rapid umbrella review with an equity lens

Community Engagement Strategies for Underrepresented Racial and Ethnic Populations

Are we being equitable enough? Lessons learned from sites lost in an implementation trial

Pragmatic randomized controlled trials: strengthening the concept through a robust international collaborative network: PRIME-9—Pragmatic Research and Innovation through Multinational Experimentation

Indigenous approaches to health assessment: a scoping review protocol

Who Are We Missing? A Principled Approach to Characterizing the Underrepresented Population

Adapting an equity-focused implementation process framework with a focus on ethnic health inequities in the Aotearoa New Zealand context

Abstract B122: Understanding Barriers to Equity in Early Phase Clinical Trials Participation for the – Underrepresented Populations (uBEEP-UP Project)- A single-center survey-based study

Patient and Public involvement in the design of an international clinical trial: Real world experience

Understanding implementation fidelity in a pragmatic randomized clinical trial in the nursing home setting:a mixed-methods examination

Addressing the need for Indigenous-specific PROMs and PREMS: A focus on methodology

Studying harms of interventions with an equity lens in randomized trials

Abstract PO5-20-05: The FOR ME (Fostering Opportunities in Research through Messaging and Education) study: Using multiple qualitative methods to develop a culturally sensitive narrative intervention to promote equity in clinical trials